Home > Insider Trading > Filing (0000899243-21-036419)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1863127	Tyra Biosciences Inc.	TYRA	()	1231

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1015747	Joseph Lewis	C/O Cay House P.o. Box N-7776 E.p. Taylor Drive Lyford Cay New Providence C5	No	No	Yes	No
1465836	Boxer Asset Management Inc.	C/O Cay House P.o. Box N-7776 E.p. Taylor Drive Lyford Cay New Providence C5 N7776	No	No	Yes	No
1465837	Boxer Capital, Llc	12860 El Camino Real, Suite 300 San Diego CA 92130	No	No	Yes	No
1465914	I. Aaron Davis	12860 El Camino Real, Suite 300 San Diego CA 92130	No	No	Yes	No
1468223	Mva Investors, Llc	12860 El Camino Real, Suite 300 San Diego CA 92130	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-09-17	5,698,359	$0.00	5,698,359	No	4	C	Direct
Common Stock	Acquisiton	2021-09-17	625,000	$16.00	6,323,359	No	4	P	Direct
Common Stock	Acquisiton	2021-09-17	288,095	$0.00	288,095	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	P	Direct
No	4	C	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2021-09-17	1,480,242	$0.00	3,844,780	$0.00
Common Stock	Series A Preferred Stock	Disposition	2021-09-17	95,516	$0.00	248,093	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-09-17	713,629	$0.00	1,853,579	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-09-17	15,401	$0.00	40,002	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Footnotes

On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
These securities are held directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) Joseph C. Lewis, (iv) MVA Investors, LLC and (v) Aaron I. Davis (collectively, the "Boxer Group"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
These securities are held directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.